Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Publication year range
1.
Medicine (Baltimore) ; 97(28): e11524, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29995822

ABSTRACT

Although fractures had high mortality and morbidity, many studies proved that fracture risk might be decreased by pharmacological therapy, although a low treatment adherence rate is observed. The aim of this study was to identify factors associated with osteoporosis treatment in postmenopausal women.A cross-sectional study was carried out from March to August 2013 at the primary care setting. Postmenopausal women were recruited. A standardized questionnaire was applied. Women who were using at least one of the following drugs at the moment of the survey were considered as current treatment: bisphosphonates, raloxifene, estrogen, calcitonin, teriparatide, or strontium ranelate. Women who had used any of the mentioned medications before the study were considered as past treatment.Of the 1025 women included in the study, 8% were on current treatment, 5.7% had past treatment, and 86.3% had not received treatment. Treated women (either current or past) had a higher rate of osteoarthritis, had more falls, had higher education level, presented a higher rate of private health insurance, and received more information about osteoporosis. They also had more dual-energy x-ray absorptiometry (DXA) scans and were more frequently diagnosed with osteoporosis by these DXA scans. The factors independently associated with treatment in the regression analysis were the DXA scan itself, the diagnosis of osteoporosis by DXA, and information about osteoporosis.Current and past treatments of osteoporosis were associated with DXA and information. These results suggest that some measures to inform women about osteoporosis and or even the popularization of DXA scans could improve the treatment.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Osteoporosis, Postmenopausal/drug therapy , Absorptiometry, Photon/statistics & numerical data , Aged , Cross-Sectional Studies , Female , Humans , Osteoporosis, Postmenopausal/complications , Patient Education as Topic/statistics & numerical data , Postmenopause , Surveys and Questionnaires
2.
Rev. AMRIGS ; 57(3): 232-233, jul.-set. 2013. ilus, tab
Article in Portuguese | LILACS | ID: biblio-998307

ABSTRACT

O hirsutismo é uma queixa frequente entre as mulheres. Apesar de ser uma alteração clínica que, isoladamente, não oferece risco à vida das pacientes, o hirsutismo pode estar associado ao desenvolvimento de doenças de maior gravidade. Nesta revisão, abordaremos alguns conceitos fi siopatogênicos relacionados ao hirsutismo, bem como as chaves diagnósticas mais atuais para o diagnóstico deste problema tão comum a diferentes especialidades dentro da Medicina


Hirsutism is a common complaint among women. Despite being a clinical alteration that alone does not pose a risk to the lives of patients, hirsutism may be associated with the development of more serious conditions. In this review, we discuss some concepts related to pathophysiological hirsutism, as well as the most current diagnostic keys to the diagnosis of this problem that is so common to different specialties within medicine


Subject(s)
Humans , Female , Women's Health , Hirsutism
3.
Clin Biochem ; 41(6): 400-6, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18222177

ABSTRACT

OBJECTIVE: Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities, in the platelets and serum, were examined in patients with uterine cervix neoplasia without treatment as well as in patients treated by conization or radiotherapy (RTX). DESIGN AND METHODS: The patients were divided based on the amount of time from the end of the treatments until the day of the blood sampling. Groups I (n=19) (conization) and III (n=11) (radiotherapy) (treated from one to five years earlier), groups II (n=19) (conization) and IV (n=16) (radiotherapy) (treated recently; up to three months earlier) and the non-treated group (cancer) (n=7). RESULTS: E-NPP and ADA in the platelets and E-NPP in the serum were decreased in all the treated groups in relation to the control and non-treated groups, while ADA in the serum was decreased only in the conization groups in relation to them. In group II, E-NPP and ADA, in the platelets, were increased in relation to group IV. CONCLUSION: The tendency of reduction for E-NPP and ADA indicates that they may act together to control nucleotide levels and it may also be speculated that surgery causes greater platelet activation contributing to the changes seen in the conization groups. In this sense, platelets seem to be more sensitive than serum.


Subject(s)
Adenosine Deaminase/blood , Phosphoric Diester Hydrolases/blood , Pyrophosphatases/blood , Uterine Cervical Neoplasms/blood , Uterine Cervical Neoplasms/enzymology , Adult , Animals , Blood Platelets/enzymology , Female , Humans , Middle Aged , Statistics as Topic , Uterine Cervical Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL